Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to find best pain block for hip fracture patients

NCT ID NCT07546903

Symptom relief Sponsor: Hitit University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two types of nerve blocks—suprainguinal fascia iliaca block (SIFI) and quadro-iliac plane block (QIPB)—for pain relief after hip fracture surgery. Researchers will enroll 70 adults undergoing hip fracture repair and measure pain scores and opioid use. The goal is to identify which block provides better pain control and fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
bupivacaine
What this could lead to
If one block proves better, it could become the standard for pain control after hip fracture surgery, reducing opioid use and speeding recovery.
What could go wrong
This is a small, early-stage comparison study with only 70 participants. Results may not apply to all patients, and neither block may be clearly superior.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult, hemodynamically stable (ASA I-III) patients undergoing hip fracture surgery.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18 years and older * ASA physical status I-III * Hemodynamically stable patients * Scheduled for surgical treatment of hip fracture * Body mass index (BMI) ≤ 35 kg/m² * Provided written informed consent Exclusion Criteria: * Refusal to participate * ASA physical status IV-V * Hemodynamically unstable patients * Surgery not completed as planned * Infection at the block site * History of allergy to local anesthetics or tramadol * Presence of neuromuscular or peripheral nerve diseases * Chronic pain conditions * Coagulopathy or ongoing anticoagulant therapy * High-dose opioid use within the last 3 days * Severe hepatic or renal insufficiency * Diabetes mellitus * Pregnancy or breastfeeding * NRS score \>7 for four consecutive hours despite multimodal analgesia * Inability to understand or use assessment tools (e.g., NRS, QoR-15) * Inability to communicate in Turkish * Inability to use PCA device due to technical reasons

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post operative pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hip fracture Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Post operative pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hitit university

    RECRUITING

    Çorum, 19100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.